We read with interest the article by Stepanova et al in a recent issue of Gut. These authors used death certificate data from the third National Health and Nutrition Examination survey (NHANES-III 1988e1994) in order to assess the impact of metabolic syndrome components on all-cause and cause-specific mortality in patients with chronic liver disease (CLD).To gain a better understanding of these unexpected findings, we believe that the authors should provide the number of deathsand the age-, and sex-standardised rates for all-cause and CVD mortality for the suspected NAFLD group and the control group.
Risk of all-cause and cardiovascular mortality in patients with chronic liver disease. [Letter]
TARGHER, Giovanni;ZOPPINI, Giacomo;
2011-01-01
Abstract
We read with interest the article by Stepanova et al in a recent issue of Gut. These authors used death certificate data from the third National Health and Nutrition Examination survey (NHANES-III 1988e1994) in order to assess the impact of metabolic syndrome components on all-cause and cause-specific mortality in patients with chronic liver disease (CLD).To gain a better understanding of these unexpected findings, we believe that the authors should provide the number of deathsand the age-, and sex-standardised rates for all-cause and CVD mortality for the suspected NAFLD group and the control group.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
